SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Sonu Singh, Akanksha Mishra, Shubha Shukla, ALCAR Exerts Neuroprotective and Pro-Neurogenic Effects by Inhibition of Glial Activation and Oxidative Stress via Activation of the Wnt/β-Catenin Signaling in Parkinsonian Rats, Molecular Neurobiology, 2015,

    CrossRef

  2. 2
    Karlijn J. Doorn, John J. P. Brevé, Benjamin Drukarch, Hendrikus W. Boddeke, Inge Huitinga, Paul J. Lucassen, Anne-Marie van Dam, Brain region-specific gene expression profiles in freshly isolated rat microglia, Frontiers in Cellular Neuroscience, 2015, 9,

    CrossRef

  3. 3
    Detlev Boison, Eleonora Aronica, Comorbidities in Neurology: Is adenosine the common link?, Neuropharmacology, 2015, 97, 18

    CrossRef

  4. 4
    Roberto E. Sica, Could astrocytes be the primary target of an offending agent causing the primary degenerative diseases of the human central nervous system? A hypothesis, Medical Hypotheses, 2015, 84, 5, 481

    CrossRef

  5. 5
    Jiahui Deng, E Lv, Jian Yang, Xiaoli Gong, Wenzhong Zhang, Xibin Liang, Jiazeng Wang, Jun Jia, Xiaomin Wang, Electroacupuncture remediates glial dysfunction and ameliorates neurodegeneration in the astrocytic α-synuclein mutant mouse model, Journal of Neuroinflammation, 2015, 12, 1

    CrossRef

  6. 6
    J. A. Smith, T. Leonardi, B. Huang, N. Iraci, B. Vega, S. Pluchino, Extracellular vesicles and their synthetic analogues in aging and age-associated brain diseases, Biogerontology, 2015, 16, 2, 147

    CrossRef

  7. 7
    Christine Kaindlstorfer, Patrick Sommer, Biljana Georgievska, Robert J. Mather, Alan R. Kugler, Werner Poewe, Gregor K. Wenning, Nadia Stefanova, Failure of Neuroprotection Despite Microglial Suppression by Delayed-Start Myeloperoxidase Inhibition in a Model of Advanced Multiple System Atrophy: Clinical Implications, Neurotoxicity Research, 2015,

    CrossRef

  8. 8
    Dominik Brück, Gregor K. Wenning, Nadia Stefanova, Lisa Fellner, Glia and alpha-synuclein in neurodegeneration: A complex interaction, Neurobiology of Disease, 2015,

    CrossRef

  9. 9
    María-Trinidad Herrero, Cristina Estrada, Layal Maatouk, Sheela Vyas, Inflammation in Parkinson’s disease: role of glucocorticoids, Frontiers in Neuroanatomy, 2015, 9,

    CrossRef

  10. 10
    Eduardo Anitua, Consuelo Pascual, Rocio Pérez-Gonzalez, Gorka Orive, Eva Carro, Intranasal PRGF-Endoret enhances neuronal survival and attenuates NF-κB-dependent inflammation process in a mouse model of Parkinson's disease, Journal of Controlled Release, 2015, 203, 170

    CrossRef

  11. 11
    Yoko S. Kaneko, Akira Ota, Akira Nakashima, Hiroshi Nagasaki, Yu Kodani, Keiji Mori, Toshiharu Nagatsu, Lipopolysaccharide treatment arrests the cell cycle of BV-2 microglial cells in G1 phase and protects them from UV light-induced apoptosis, Journal of Neural Transmission, 2015, 122, 2, 187

    CrossRef

  12. 12
    Junchao Tong, Lee-Cyn Ang, Belinda Williams, Yoshiaki Furukawa, Paul Fitzmaurice, Mark Guttman, Isabelle Boileau, Oleh Hornykiewicz, Stephen J. Kish, Low levels of astroglial markers in Parkinson’s disease: relationship to α-synuclein accumulation, Neurobiology of Disease, 2015, 82, 243

    CrossRef

  13. 13
    Travis J. Cook, Jake G. Hoekstra, David L. Eaton, Jing Zhang, Mortalin is Expressed by Astrocytes and Decreased in the Midbrain of Parkinson's Disease Patients, Brain Pathology, 2015, 25, 5
  14. 14
    Jihye Park, Chae-Seok Lim, Hyunhyo Seo, Chung-Ah Park, Min Zhuo, Bong-Kiun Kaang, Kyungmin Lee, Pain perception in acute model mice of Parkinson’s disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), Molecular Pain, 2015, 11, 1

    CrossRef

  15. 15
    Manuel Rodriguez, Clara Rodriguez-Sabate, Ingrid Morales, Alberto Sanchez, Magdalena Sabate, Parkinson's disease as a result of aging, Aging Cell, 2015, 14, 3
  16. 16
    Yuya Takahashi, Takashi Kanbayashi, Masamitsu Hoshikawa, Aya Imanishi, Yohei Sagawa, Kou Tsutsui, Yasuhiro Takeda, Hiroaki Kusanagi, Seiji Nishino, Tetsuo Shimizu, Relationship of orexin (hypocretin) system and astrocyte activation in Parkinson's disease with hypersomnolence, Sleep and Biological Rhythms, 2015, 13, 3
  17. 17
    Cristiane Batassini, Núbia Broetto, Lucas Silva Tortorelli, Milene Borsoi, Caroline Zanotto, Fabiana Galland, Tadeu Mello Souza, Marina Concli Leite, Carlos-Alberto Gonçalves, Striatal Injury with 6-OHDA Transiently Increases Cerebrospinal GFAP and S100B, Neural Plasticity, 2015, 2015, 1

    CrossRef

  18. 18
    Ingrid Morales, Alberto Sanchez, Clara Rodriguez-Sabate, Manuel Rodriguez, The degeneration of dopaminergic synapses in Parkinson's disease: A selective animal model, Behavioural Brain Research, 2015, 289, 19

    CrossRef

  19. 19
    V. Sanchez-Guajardo, N. Tentillier, M. Romero-Ramos, The relation between α-synuclein and microglia in Parkinson’s disease: Recent developments, Neuroscience, 2015, 302, 47

    CrossRef

  20. 20
    Giuseppe Pasqualetti, David J. Brooks, Paul Edison, The Role of Neuroinflammation in Dementias, Current Neurology and Neuroscience Reports, 2015, 15, 4

    CrossRef

  21. 21
    Kevin R. Doty, Marie-Victoire Guillot-Sestier, Terrence Town, The role of the immune system in neurodegenerative disorders: Adaptive or maladaptive?, Brain Research, 2015, 1617, 155

    CrossRef

  22. 22
    Jieqiong Chen, James D. Mills, Glenda M. Halliday, Michael Janitz, The role of transcriptional control in multiple system atrophy, Neurobiology of Aging, 2015, 36, 1, 394

    CrossRef

  23. 23
    José Christian Machado Ximenes, Kelly Rose Tavares Neves, Luzia Kalyne A. M. Leal, Marta Regina Santos do Carmo, Gerly Anne de Castro Brito, Maria da Graça Naffah-Mazzacoratti, Ésper Abrão Cavalheiro, Glauce Socorro de Barros Viana, Valproic Acid Neuroprotection in the 6-OHDA Model of Parkinson’s Disease Is Possibly Related to Its Anti-Inflammatory and HDAC Inhibitory Properties, Journal of Neurodegenerative Diseases, 2015, 2015, 1

    CrossRef

  24. 24
    Amit Khairnar, Lucia Frau, Antonio Plumitallo, Micaela Morelli, Nicola Simola, Antagonism of Adenosine A1or A2AReceptors Amplifies the Effects of MDMA on Glial Activation in the Mouse Brain: Relevance to Caffeine–MDMA Interactions, Journal of Caffeine Research, 2014, 4, 2, 41

    CrossRef

  25. 25
    Ricardo Cabezas, Marcos Ávila, Janneth Gonzalez, Ramon Santos El-Bachá, Eliana Báez, Luis Miguel García-Segura, Juan Camilo Jurado Coronel, Francisco Capani, Gloria Patricia Cardona-Gomez, George E. Barreto, Astrocytic modulation of blood brain barrier: perspectives on Parkinson’s disease, Frontiers in Cellular Neuroscience, 2014, 8,

    CrossRef

  26. 26
    Giselle Charron, Evelyne Doudnikoff, Marie-Helene Canron, Qin Li, Céline Véga, Sebastien Marais, Jérôme Baufreton, Anne Vital, Stéphane H. R. Oliet, Erwan Bezard, Astrocytosis in parkinsonism: considering tripartite striatal synapses in physiopathology?, Frontiers in Aging Neuroscience, 2014, 6,

    CrossRef

  27. 27
    He-Jin Lee, Eun-Jin Bae, Seung-Jae Lee, Extracellular α-synuclein—a novel and crucial factor in Lewy body diseases, Nature Reviews Neurology, 2014, 10, 2, 92

    CrossRef

  28. 28
    Ewa Papuć, Jacek Kurzepa, Ewa Kurys-Denis, Aneta Grabarska, Witold Krupski, Konrad Rejdak, Humoral response against glial derived antigens in Parkinson's disease, Neuroscience Letters, 2014, 566, 77

    CrossRef

  29. 29
    Kathrin Hemmer, Mingyue Zhang, Thea van Wüllen, Marna Sakalem, Natalia Tapia, Aidos Baumuratov, Christian Kaltschmidt, Barbara Kaltschmidt, Hans R. Schöler, Weiqi Zhang, Jens C. Schwamborn, Induced Neural Stem Cells Achieve Long-Term Survival and Functional Integration in the Adult Mouse Brain, Stem Cell Reports, 2014, 3, 3, 423

    CrossRef

  30. 30
    Fares Bassil, Pierre-Olivier Fernagut, Erwan Bezard, Wassilios G. Meissner, Insulin, IGF-1 and GLP-1 signaling in neurodegenerative disorders: Targets for disease modification?, Progress in Neurobiology, 2014, 118, 1

    CrossRef

  31. 31
    T. Nakaji-Hirabayashi, H. Kitano, Interleukin-10 chimeric protein to protect transplanted neural progenitor cells from immune responses, J. Mater. Chem. B, 2014, 2, 48, 8598

    CrossRef

  32. 32
    Gabor G. Kovacs, Leonid Breydo, Ryan Green, Viktor Kis, Gina Puska, Péter Lőrincz, Laura Perju-Dumbrava, Regina Giera, Walter Pirker, Mirjam Lutz, Ingolf Lachmann, Herbert Budka, Vladimir N. Uversky, Kinga Molnár, Lajos László, Intracellular processing of disease-associated α-synuclein in the human brain suggests prion-like cell-to-cell spread, Neurobiology of Disease, 2014, 69, 76

    CrossRef

  33. 33
    Rajeev Shrestha, Owain Millington, James Brewer, Kumlesh K. Dev, Trevor J. Bushell, Lymphocyte-mediated neuroprotection in in vitro models of excitotoxicity involves astrocytic activation and the inhibition of MAP kinase signalling pathways, Neuropharmacology, 2014, 76, 184

    CrossRef

  34. 34
    Ivo F. Scheiber, Julian F.B. Mercer, Ralf Dringen, Metabolism and functions of copper in brain, Progress in Neurobiology, 2014, 116, 33

    CrossRef

  35. 35
    Wolfgang J Streit, Qing-Shan Xue, Jasmin Tischer, Ingo Bechmann, Microglial pathology, Acta Neuropathologica Communications, 2014, 2, 1, 142

    CrossRef

  36. 36
    Marianna Sikorska, Patricia Lanthier, Harvey Miller, Melissa Beyers, Caroline Sodja, Bogdan Zurakowski, Sandhya Gangaraju, Siyaram Pandey, Jagdeep K. Sandhu, Nanomicellar formulation of coenzyme Q10 (Ubisol-Q10) effectively blocks ongoing neurodegeneration in the mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model: potential use as an adjuvant treatment in Parkinson's disease, Neurobiology of Aging, 2014, 35, 10, 2329

    CrossRef

  37. 37
    Irina Surgucheva, Kathy L Newell, Jeffrey Burns, Andrei Surguchov, New α- and γ-synuclein immunopathological lesions in human brain, Acta Neuropathologica Communications, 2014, 2, 1

    CrossRef

  38. 38
    Pamela Brambilla Bagatini, Léder Leal Xavier, Laura Tartari Neves, Lisiani Saur, Sílvia Barbosa, Pedro Porto Alegre Baptista, Otávio Américo Augustin, Priscylla Nunes de Senna, Régis Gemerasca Mestriner, André Arigony Souto, Matilde Achaval, Resveratrol prevents akinesia and restores neuronal tyrosine hydroxylase immunoreactivity in the substantia nigra pars compacta of diabetic rats, Brain Research, 2014, 1592, 101

    CrossRef

  39. 39
    Glenda E. Gillies, Ilse S. Pienaar, Shiv Vohra, Zahi Qamhawi, Sex differences in Parkinson’s disease, Frontiers in Neuroendocrinology, 2014, 35, 3, 370

    CrossRef

  40. 40
    Manuel Rodriguez, Ingrid Morales, Clara Rodriguez-Sabate, Alberto Sanchez, Rafael Castro, Jose Miguel Brito, Magdalena Sabate, The degeneration and replacement of dopamine cells in Parkinson’s disease: the role of aging, Frontiers in Neuroanatomy, 2014, 8,

    CrossRef

  41. 41
    Marta R.S. Carmo, Ana Paula F. Menezes, Ana Carla L. Nunes, Anna Pliássova, Anabela P. Rolo, Carlos M. Palmeira, Rodrigo A. Cunha, Paula M. Canas, Geanne M. Andrade, The P2X7 receptor antagonist Brilliant Blue G attenuates contralateral rotations in a rat model of Parkinsonism through a combined control of synaptotoxicity, neurotoxicity and gliosis, Neuropharmacology, 2014, 81, 142

    CrossRef

  42. 42
    Anne H. P. Jansen, Eric A. J. Reits, Elly M. Hol, The ubiquitin proteasome system in glia and its role in neurodegenerative diseases, Frontiers in Molecular Neuroscience, 2014, 7,

    CrossRef

  43. 43
    Yvona Mazurová, Miroslava Anderova, Ivana Němečková, Aleš Bezrouk, Transgenic Rat Model of Huntington’s Disease: A Histopathological Study and Correlations with Neurodegenerative Process in the Brain of HD Patients, BioMed Research International, 2014, 2014, 1

    CrossRef

  44. 44
    Guy Laureys, Sarah Gerlo, Anneleen Spooren, Frauke Demol, Jacques De Keyser, Joeri L Aerts, β2-adrenergic agonists modulate TNF-α induced astrocytic inflammatory gene expression and brain inflammatory cell populations, Journal of Neuroinflammation, 2014, 11, 1, 21

    CrossRef

  45. 45
    Stephen J. Kish, The Effects of Drug Abuse on the Human Nervous System, 2014,

    CrossRef

  46. 46
    Ivo F. Scheiber, Ralf Dringen, Astrocyte functions in the copper homeostasis of the brain, Neurochemistry International, 2013, 62, 5, 556

    CrossRef

  47. 47
    Ji Hyeon Ahn, Joon Ha Park, Bing Chun Yan, Jae-Chul Lee, Jung Hoon Choi, Choong Hyun Lee, Ki-Yeon Yoo, In Koo Hwang, Jin Sang Kim, Hyung-Cheul Shin, Moo-Ho Won, Comparison of Alpha-Synuclein Immunoreactivity in the Hippocampus Between the Adult and Aged Beagle Dogs, Cellular and Molecular Neurobiology, 2013, 33, 1, 75

    CrossRef

  48. 48
    Amanda N Sacino, Michael A Thomas, Carolina Ceballos-Diaz, Pedro E Cruz, Awilda M Rosario, Jada Lewis, Benoit I Giasson, Todd E Golde, Conformational templating of α-synuclein aggregates in neuronal-glial cultures, Molecular Neurodegeneration, 2013, 8, 1, 17

    CrossRef

  49. 49
    Lucia Frau, Nicola Simola, Micaela Morelli, Contribution of Caffeine to the Psychostimulant, Neuroinflammatory and Neurotoxic Effects of Amphetamine-Related Drugs, Journal of Caffeine Research, 2013, 3, 2, 79

    CrossRef

  50. 50
    Chongwang Chang, Hongjuan Lang, Ning Geng, Jing Wang, Nan Li, Xuelian Wang, Exosomes of BV-2 cells induced by alpha-synuclein: Important mediator of neurodegeneration in PD, Neuroscience Letters, 2013, 548, 190

    CrossRef

  51. 51
    Yi Guo, Huarong Yang, Xiong Deng, Zhi Song, Zhijian Yang, Wei Xiong, Lamei Yuan, Hongbo Xu, Sheng Deng, Hao Deng, Genetic analysis of the S100B gene in Chinese patients with Parkinson disease, Neuroscience Letters, 2013, 555, 134

    CrossRef

  52. 52
    Carlos Barcia, Glial-Mediated Inflammation Underlying Parkinsonism, Scientifica, 2013, 2013, 1

    CrossRef

  53. 53
    Nirit Lev, Yael Barhum, Tali Ben-Zur, Eldad Melamed, Israel Steiner, Daniel Offen, Knocking Out DJ-1 Attenuates Astrocytes Neuroprotection Against 6-Hydroxydopamine Toxicity, Journal of Molecular Neuroscience, 2013, 50, 3, 542

    CrossRef

  54. 54
    Pei Xu, Dabing Li, Xiaotong Tang, Xiaohang Bao, Jing Huang, Yongping Tang, Yang Yang, Haiwei Xu, Xiaotang Fan, LXR Agonists: New Potential Therapeutic Drug for Neurodegenerative Diseases, Molecular Neurobiology, 2013, 48, 3, 715

    CrossRef

  55. 55
    Lucia Frau, Nicola Simola, Antonio Plumitallo, Micaela Morelli, Microglial and astroglial activation by 3,4-methylenedioxymethamphetamine (MDMA) in mice depends on S(+) enantiomer and is associated with an increase in body temperature and motility, Journal of Neurochemistry, 2013, 124, 1
  56. 56
    Giulia Costa, Lucia Frau, Jadwiga Wardas, Annalisa Pinna, Antonio Plumitallo, Micaela Morelli, MPTP-induced dopamine neuron degeneration and glia activation is potentiated in MDMA-pretreated mice, Movement Disorders, 2013, 28, 14
  57. 57
    Sara Sepe, Cesar Payan-Gomez, Chiara Milanese, Jan H. Hoeijmakers, Pier G. Mastroberardino, Nucleotide excision repair in chronic neurodegenerative diseases, DNA Repair, 2013, 12, 8, 568

    CrossRef

  58. 58
    Andrew N. Bankston, Mariana D. Mandler, Yue Feng, Oligodendroglia and neurotrophic factors in neurodegeneration, Neuroscience Bulletin, 2013, 29, 2, 216

    CrossRef

  59. 59
    S. M. Gentleman, Review: Microglia in protein aggregation disorders: friend or foe?, Neuropathology and Applied Neurobiology, 2013, 39, 1
  60. 60
    Tomasz Brudek, Kristian Winge, Tina Klitmøller Agander, Bente Pakkenberg, Screening of Toll-Like Receptors Expression in Multiple System Atrophy Brains, Neurochemical Research, 2013, 38, 6, 1252

    CrossRef

  61. 61
    Ingrid Morales, Catalina Yanos, Clara Rodriguez-Sabate, Alberto Sanchez, Manuel Rodriguez, Striatal Glutamate Degenerates Thalamic Neurons, Journal of Neuropathology & Experimental Neurology, 2013, 72, 4, 286

    CrossRef

  62. 62
    Manuel J. Rodríguez, Margot Martínez-Moreno, Francisco J. Ortega, Nicole Mahy, Targeting Microglial KATP Channels to Treat Neurodegenerative Diseases: A Mitochondrial Issue, Oxidative Medicine and Cellular Longevity, 2013, 2013, 1

    CrossRef

  63. 63
    Lisa Fellner, Nadia Stefanova, The Role of Glia in Alpha-Synucleinopathies, Molecular Neurobiology, 2013, 47, 2, 575

    CrossRef

  64. 64
    Michela Deleidi, Thomas Gasser, The role of inflammation in sporadic and familial Parkinson’s disease, Cellular and Molecular Life Sciences, 2013, 70, 22, 4259

    CrossRef

  65. 65
    Lisa Fellner, Regina Irschick, Kathrin Schanda, Markus Reindl, Lars Klimaschewski, Werner Poewe, Gregor K. Wenning, Nadia Stefanova, Toll-like receptor 4 is required for α-synuclein dependent activation of microglia and astroglia, Glia, 2013, 61, 3
  66. 66
    Vanesa Sanchez-Guajardo, Ambra Annibali, Poul Henning Jensen, Marina Romero-Ramos, α-Synuclein Vaccination Prevents the Accumulation of Parkinson Disease–Like Pathologic Inclusions in Striatum in Association With Regulatory T Cell Recruitment in a Rat Model, Journal of Neuropathology & Experimental Neurology, 2013, 72, 7, 624

    CrossRef

  67. You have free access to this content67
    Lorraine V. Kalia, Suneil K. Kalia, Pamela J. McLean, Andres M. Lozano, Anthony E. Lang, α-Synuclein oligomers and clinical implications for Parkinson disease, Annals of Neurology, 2013, 73, 2
  68. 68
    I. Lastres-Becker, A. Ulusoy, N. G. Innamorato, G. Sahin, A. Rabano, D. Kirik, A. Cuadrado,  -Synuclein expression and Nrf2 deficiency cooperate to aggravate protein aggregation, neuronal death and inflammation in early-stage Parkinson's disease, Human Molecular Genetics, 2012, 21, 14, 3173

    CrossRef

  69. 69
    Micaela Morelli, Lucia Frau, Nicola Simola, Alteration in the progression of dopamine neuron degeneration: May caffeine offer new perspective?, Experimental Neurology, 2012, 237, 1, 218

    CrossRef

  70. 70
    Tarja A Juopperi, Woon Kim, Cheng-Hsuan Chiang, Huimei Yu, Russell L Margolis, Christopher A Ross, Guo-li Ming, Hongjun Song, Astrocytes generated from patient induced pluripotent stem cells recapitulate features of Huntington’s disease patient cells, Molecular Brain, 2012, 5, 1, 17

    CrossRef

  71. 71
    A. J. Petersen, S. A. Rimkus, D. A. Wassarman, ATM kinase inhibition in glial cells activates the innate immune response and causes neurodegeneration in Drosophila, Proceedings of the National Academy of Sciences, 2012, 109, 11, E656

    CrossRef

  72. 72
    Glenda Halliday, Heather McCann, Claire Shepherd, Evaluation of the Braak hypothesis: how far can it explain the pathogenesis of Parkinson's disease?, Expert Review of Neurotherapeutics, 2012, 12, 6, 673

    CrossRef

  73. 73
    Akshata A Almad, Nicholas J Maragakis, Glia: an emerging target for neurological disease therapy, Stem Cell Research & Therapy, 2012, 3, 5, 37

    CrossRef

  74. 74
    R. Waller, M.N. Woodroofe, S. Francese, P.R. Heath, S.B. Wharton, P.G. Ince, B. Sharrack, J.E. Simpson, Isolation of enriched glial populations from post-mortem human CNS material by immuno-laser capture microdissection, Journal of Neuroscience Methods, 2012, 208, 2, 108

    CrossRef

  75. 75
    A. Lanciotti, M. S. Brignone, P. Molinari, S. Visentin, C. De Nuccio, G. Macchia, C. Aiello, E. Bertini, F. Aloisi, T. C. Petrucci, E. Ambrosini, Megalencephalic leukoencephalopathy with subcortical cysts protein 1 functionally cooperates with the TRPV4 cation channel to activate the response of astrocytes to osmotic stress: dysregulation by pathological mutations, Human Molecular Genetics, 2012, 21, 10, 2166

    CrossRef

  76. 76
    Yoko S. Kaneko, Akira Nakashima, Keiji Mori, Toshiharu Nagatsu, Ikuko Nagatsu, Akira Ota, Microglial Activation in Neuroinflammation: Implications for the Etiology of Neurodegeneration, Neurodegenerative Diseases, 2012, 10, 1-4, 100

    CrossRef

  77. 77
    I. Ferrer, I. López-Gonzalez, M. Carmona, E. Dalfó, A. Pujol, A. Martínez, Neurochemistry and the non-motor aspects of PD, Neurobiology of Disease, 2012, 46, 3, 508

    CrossRef

  78. 78
    Sudarshan Phani, John D. Loike, Serge Przedborski, Neurodegeneration and Inflammation in Parkinson's disease, Parkinsonism & Related Disorders, 2012, 18, S207

    CrossRef

  79. 79
    Kurt A. Jellinger, Neuropathology of sporadic Parkinson's disease: Evaluation and changes of concepts, Movement Disorders, 2012, 27, 1
  80. 80
    Toshikuni Sasaoka, Oxidative stress in neurodegenerative diseases: friend and foe, Clinical and Experimental Pharmacology and Physiology, 2012, 39, 7
  81. 81
    Michela Deleidi, Walter Maetzler, Protein Clearance Mechanisms of Alpha-Synuclein and Amyloid-Beta in Lewy Body Disorders, International Journal of Alzheimer's Disease, 2012, 2012, 1

    CrossRef

  82. 82
    K. Sathe, W. Maetzler, J. D. Lang, R. B. Mounsey, C. Fleckenstein, H. L. Martin, C. Schulte, S. Mustafa, M. Synofzik, Z. Vukovic, S. Itohara, D. Berg, P. Teismann, S100B is increased in Parkinson's disease and ablation protects against MPTP-induced toxicity through the RAGE and TNF-  pathway, Brain, 2012, 135, 11, 3336

    CrossRef

  83. 83
    Ingrid Morales, Manuel Rodriguez, Self-induced accumulation of glutamate in striatal astrocytes and basal ganglia excitotoxicity, Glia, 2012, 60, 10
  84. 84
    Silvia Sorce, Karl-Heinz Krause, Vincent Jaquet, Targeting NOX enzymes in the central nervous system: therapeutic opportunities, Cellular and Molecular Life Sciences, 2012, 69, 14, 2387

    CrossRef

  85. 85
    Kurt Jellinger, The role of α-synuclein in neurodegeneration — An update, Translational Neuroscience, 2012, 3, 2

    CrossRef

  86. 86
    Kemal Ugur Tufekci, Ralph Meuwissen, Sermin Genc, Kursad Genc, Advances in Protein Chemistry and Structural Biology Volume 88, 2012,

    CrossRef

  87. 87
    Lisa Fellner, Kurt A. Jellinger, Gregor K. Wenning, Nadia Stefanova, Glial dysfunction in the pathogenesis of α-synucleinopathies: emerging concepts, Acta Neuropathologica, 2011, 121, 6, 675

    CrossRef

  88. 88
    Seung-Jae Lee, Hee-Sun Lim, Eliezer Masliah, He-Jin Lee, Protein aggregate spreading in neurodegenerative diseases: Problems and perspectives, Neuroscience Research, 2011, 70, 4, 339

    CrossRef

  89. 89
    Shawn Hayley, Darcy Litteljohn, Inflammatory Roads to Neurodegeneration: A Focus on Parkinson's and Alzheimer's Disease,